Target intelligence / Profile preview

Muscarinic acetylcholine receptor subtype M1 (M1)

Target
M1
Molecular classification
G protein-coupled receptor, Receptor, Metabotropic receptor (distinct from nicotinic acetylcholine receptor, which is an ion channel)
01

Overview

Muscarinic acetylcholine receptors are a family of five G protein-coupled receptor subtypes (M1–M5) found in central and peripheral tissues. All are activated by acetylcholine and mediate a variety of physiological responses through coupling to G proteins (M1, M3, M5: Gq; M2, M4: Gi), impacting neurotransmission, muscle contraction/relaxation, glandular secretion, and cognitive and cardiac functions. Each subtype displays unique tissue distributions and physiological roles. Their high conservation in orthosteric binding sites presents drug development challenges; thus, current research is focused on allosteric site targeting for improved selectivity and safety. These receptors are widely studied in pharmacology for their crucial roles in both normal function and disease pathophysiology across nervous, cardiovascular, and respiratory systems.

Other names
mAChR (Muscarinic acetylcholine receptor)Chrm1, Chrm2, Chrm3, Chrm4, Chrm5 (gene symbols)M1, M2, M3, M4, M5
02

Mechanism of action

Orthosteric antagonism/agonism (direct acetylcholine competition). Allosteric modulation (targeting non-conserved receptor sites to alter function or drug selectivity). Gq-mediated stimulation (M1, M3, M5: lead to increased phospholipase C activity, DAG/IP3, intracellular calcium rise). Gi-mediated inhibition (M2, M4: inhibit adenylyl cyclase, decrease cAMP, decrease PKA activity).

03

Biological functions

Signal transductionRegulation of neurotransmissionModulation of cardiac contractility and heart rateSmooth muscle contraction and relaxationGlandular secretionCognitive functionDopamine release
04

Disease associations

Neurological disorders (e.g. Alzheimer’s disease, schizophrenia, drug addiction)Cardiovascular diseaseGastrointestinal disordersAirway diseases (e.g. asthma, bronchoconstriction)Myelodysplastic syndrome and anemia (via M4)Other (broad tissue expression and roles)
05

Safety considerations

Poor drug selectivity among subtypes increases risk for off-target side effectsAdverse effects include dry mouth, blurred vision, tachycardia, constipation, cognitive impairment (especially with non-selective antagonists)Allosteric targeting may reduce these risks but is still under research
06

Interacting drugs

Tiotropium (inverse agonist)

7 more in the full profile.

07

Biomarkers

None routinely used for patient selection, but gene/protein expression (Chrm1–5 mRNA) can be measured experimentallyPotential for future development as pharmacodynamic or diagnostic biomarkers

Beyond the preview

Go deeper on Muscarinic acetylcholine receptor subtype M1 (M1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscarinic acetylcholine receptor subtype M1 (M1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call